-
Signature
-
/s/ Ana Mondedeu Insunza, as Associate General Counsel and Secretary of Insud Pharma, S.L.
-
Stock symbol
-
GRNA
-
Transactions as of
-
May 29, 2023
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
6/8/2023, 05:32 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
GRNA |
Common Stock, par value $0.0001 per share |
|
|
|
|
|
2.55M |
May 29, 2023 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
As discussed in the Reporting Person's Schedule 13D filed on June 8, 2023, a result of the entry of the Reporting Person and other stockholders of the Issuer (the "Rollover Stockholders") into contribution and exchange agreements, dated May 29, 2023, between each of them and SW ParentCo, Inc., a Delaware corporation, in connection with the Issuer's signed merger agreement, the Reporting Person may be deemed to be member, along with the other Rollover Stockholders, of a "group" within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which "group" collectively owns 120,521,038 shares of the Issuer's outstanding Common Stock. The Common Stock reported herein, which is the only Common Stock in which the Reporting Person has reportable pecuniary interest, does not include any Common Stock which may be beneficially owned by any of the other parties to documents relating to the merger agreement not deemed to be in the "group." The Rollover Stockholders in the "group" other than the Reporting Person herein have been notified by the Issuer that such individuals and/or entities may beneficially own certain Common Stock and need to file separate beneficial ownership reports with the SEC related thereto. Neither the filing of this Form 3 nor any of its contents, however, shall be deemed to constitute an admission by the Reporting Person that it is the beneficial owner of any of the Common Stock beneficially owned in the aggregate by other members of the "group" and their respective affiliates for purposes of Section 13(d)(3) of the Exchange Act or for any other purpose, and such beneficial ownership and pecuniary interest is expressly disclaimed.